GPCR
Structure Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$47.34
+0.00%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.32
- Revenue estimate
- $45.5M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.49
- EPS estimate
- -$0.39
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -7.7%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $92
- PT range
- $70 – $110
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026